Theseus Pharmaceuticals (THRX) –
-
Form 15-12G Theseus Pharmaceuticals,
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form EFFECT Theseus Pharmaceuticals,
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: Yi Kathy
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: Stein Steven H
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: GORDON CARL L
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: OrbiMed Genesis GP LLC
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: Dukes Iain D.
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: HAYDEN DONALD J JR
-
Form 4 Theseus Pharmaceuticals, For: Feb 14 Filed by: Dahms Bradford D.
-
Form S-8 POS Theseus Pharmaceuticals,
-
Form S-8 POS Theseus Pharmaceuticals,
-
Form POS AM Theseus Pharmaceuticals,
-
Form 8-K Theseus Pharmaceuticals, For: Feb 14
-
Form SC TO-T/A Theseus Pharmaceuticals, Filed by: Concentra Merger Sub II, Inc.
-
Form SC 14D9/A Theseus Pharmaceuticals, Filed by: Theseus Pharmaceuticals, Inc.
-
Form 25-NSE Theseus Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
-
Theseus Pharmaceuticals Announces Closing of Tender Offer
-
Form SC 13G/A Theseus Pharmaceuticals, Filed by: Frazier Life Sciences Public Fund, L.P.
-
Form SC 14D9/A Theseus Pharmaceuticals, Filed by: Theseus Pharmaceuticals, Inc.
-
Form SC TO-T/A Theseus Pharmaceuticals, Filed by: Concentra Merger Sub II, Inc.
-
Form SC 14D9/A Theseus Pharmaceuticals, Filed by: Theseus Pharmaceuticals, Inc.
-
Form SC TO-T/A Theseus Pharmaceuticals, Filed by: Concentra Merger Sub II, Inc.
-
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 14D9 Theseus Pharmaceuticals, Filed by: Theseus Pharmaceuticals, Inc.
-
Form SC TO-T Theseus Pharmaceuticals, Filed by: Concentra Merger Sub II, Inc.
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
-
Form SC14D9C Theseus Pharmaceuticals, Filed by: Theseus Pharmaceuticals, Inc.
-
Form 8-K Theseus Pharmaceuticals, For: Dec 21
-
Theseus Pharmaceuticals (THRX) Acquired by Concentra Biosciences for $3.90-$4.05/sh Cash Plus CVR
-
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
-
Form 8-K Theseus Pharmaceuticals, For: Nov 29
-
Form 8-K Theseus Pharmaceuticals, For: Nov 22
-
Theseus Pharmaceuticals (THRX) Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital and OrbiMed Advisors; Unsolicited Proposal from Concentra Biosciences
-
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: Foresite Capital Fund V, L.P.
-
Form SC 13D Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form 10-Q Theseus Pharmaceuticals, For: Sep 30
-
Form NT 10-Q Theseus Pharmaceuticals, For: Sep 30
-
Form 8-K Theseus Pharmaceuticals, For: Nov 06
-
Theseus Pharmaceuticals (THRX) to Explore Strategic Alternatives, Plans Workforce Reduction
-
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
-
Theseus Pharmaceuticals (THRX) Halted, News Pending
-
Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conference
-
Form 4 Theseus Pharmaceuticals, For: Nov 06 Filed by: Shakespeare William
-
Form 8-K Theseus Pharmaceuticals, For: Oct 27
-
Form SC 13G/A Theseus Pharmaceuticals, Filed by: FMR LLC
Back to THRX Stock Lookup
